← Back to Patent Explorer
US4716155A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphorus containing compounds and hypotensive use thereof

Assignee: ER Squibb and Sons LLC
•
Filing: 1985-01-25
•
Granted: 1987-12-29
•
Expires: 2005-01-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Phosphorus containing compounds of the formula <IMAGE> wherein X is a substituted or unsubstituted imino or amino acid and A is <IMAGE> These compounds possess angiotensin converting enzyme activity and are thus useful as hypertensive agents.

Inventors

  • 👤 Donald S. Karanewsky
  • 👤 Edward W. Petrillo, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 18:05
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6561; C07F9/65615; C07F9/28; C07F9/30; C07F9/301; C07F9/306; C07F9/32; C07F9/3205; C07F9/3211; C07F9/3241; C07F9/38; C07F9/3804; C07F9/3808; C07F9/3882; C07F9/40; C07F9/4003; C07F9/4006; C07F9/4056; C07F9/44; C07F9/4461; C07F9/4484; C07F9/4492; C07F9/48; C07F9/4808; C07F9/4816; C07F9/553; C07F9/5537; C07F9/568; C07F9/572; C07F9/5728; C07F9/576; C07F9/59; C07F9/62; C07F9/645; C07F9/6503; C07F9/6506; C07F9/6536; C07F9/6539

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 350 words
A compound of the formula ##STR463## and a pharmaceutically acceptable salt thereof wherein: R 1 and R 2 are independently selected from the group consisting of hydrogen, lower alkyl, halo substituted lower alkyl, ##STR464## and amino substituted lower alkyl; q is zero or an integer from 1 to 7; R 23 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR465## R 7 is hydrogen, lower alkyl, halogen, keto, hydroxy, ##STR466## a 1- or 2-naphthyl of the formula ##STR467## a 1- or 2-naphthyloxy of the formula ##STR468## or a 1- or 2-naphthylthio of the formula ##STR469## R 8 is keto, halogen, ##STR470## --O--lower alkyl, a 1- or 2-naphthyloxy of the formula ##STR471## or a 1- or 2-naphthylthio of the formula ##STR472## R 9 is keto or ##STR473## R 10 is halogen or --Y--R 16 ; R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy or 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethy;, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; R 14 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy; m is zero, one, two or three; p is one, two or three provided that p is more than one only if R 13 or R 14 is hydrogen, methyl, methoxy, chloro or fluoro; R 15 is hydrogen or lower alkyl of 1 to 4 carbons; Y is oxygen or sulfur; R 16 is lower alkyl of 1 to 4 carbons or ##STR474## r is an integer from 1 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR475## wherein R 17 is hydrogen, lower alkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl, or R 17 and R 18 taken together are --(CH 2 ) 2 --, --(CH 2 ) 3 --, --CH═CH--, or ##STR476## R 19 is lower alkyl, benzyl, or phenethyl; and R 20 is hydrogen, lower alkyl, benzyl or phenethyl.
Claim 2
Dependent Claim 350 words
A compound of the formula ##STR463## and a pharmaceutically acceptable salt thereof wherein: R 1 and R 2 are independently selected from the group consisting of hydrogen, lower alkyl, halo substituted lower alkyl, ##STR464## and amino substituted lower alkyl; q is zero or an integer from 1 to 7; R 23 is hydrogen, lower alkyl, halo substituted lower alkyl, ##STR465## R 7 is hydrogen, lower alkyl, halogen, keto, hydroxy, ##STR466## a 1- or 2-naphthyl of the formula ##STR467## a 1- or 2-naphthyloxy of the formula ##STR468## or a 1- or 2-naphthylthio of the formula ##STR469## R 8 is keto, halogen, ##STR470## --O--lower alkyl, a 1- or 2-naphthyloxy of the formula ##STR471## or a 1- or 2-naphthylthio of the formula ##STR472## R 9 is keto or ##STR473## R 10 is halogen or --Y--R 16 ; R 13 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy or 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethy;, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl; R 14 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy; m is zero, one, two or three; p is one, two or three provided that p is more than one only if R 13 or R 14 is hydrogen, methyl, methoxy, chloro or fluoro; R 15 is hydrogen or lower alkyl of 1 to 4 carbons; Y is oxygen or sulfur; R 16 is lower alkyl of 1 to 4 carbons or ##STR474## r is an integer from 1 to 4; R 3 and R 6 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and ##STR475## wherein R 17 is hydrogen, lower alkyl, or phenyl, and R 18 is hydrogen, lower alkyl, lower alkoxy, phenyl, or R 17 and R 18 taken together are --(CH 2 ) 2 --, --(CH 2 ) 3 --, --CH═CH--, or ##STR476## R 19 is lower alkyl, benzyl, or phenethyl; and R 20 is hydrogen, lower alkyl, benzyl or phenethyl.
Claim 3
Dependent Claim 275 words
A compound of claim 1 wherein: R 7 is hydrogen, hydroxy, chloro, fluoro, lower alkyl of 1 to 4 carbons, cyclohexyl, amino, --O--lower alkyl wherein lower alkyl is of 1 to 4 carbons, ##STR477## 1- or 2-naphthyloxy, --S--lower alkyl wherein lower alkyl is of 1 to 4 carbons, ##STR478## or a 1- or 2-naphthylthio; R 8 is --O--lower alkyl wherein lower alkyl is of 1 to 4 carbons, --S--lower alkyl wherein lower alkyl is of 1 to 4 carbons, ##STR479## R 9 is phenyl, 2-hydroxyphenyl, or 4-hydroxyphenyl; R 10 are both fluoro, both chloro, or --Y--R 16 ; Y is oxygen or sulfur; R 16 is lower alkyl of 1 to 4 carbons or the R 16 groups join to complete an unsubstituted 5- or 6-membered ring or said ring in which one or more of the carbons has a methyl or dimethyl substituent; m is zero, one or two; R 13 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, or hydroxy; R 1 is lower alkyl of 1 to 4 carbons or ##STR480## wherein q is zero or an integer from 1 to 4 and R 13 is as defined above; R 2 is hydrogen, lower alkyl of 1 to 4 carbons, or ##STR481## wherein q and R 13 are as defined above; R 23 is lower alkyl of 1 to 4 carbons or amino substituted lower alkyl of 1 to 4 carbons; R 3 and R 6 are independently selected from hydrogen, alkali metal salt, lower alkyl of 1 to 4 carbons, or ##STR482## R 17 is hydrogen or methyl; and R 18 is lower alkyl of 1 to 4 carbons or phenyl.
Claim 4
Dependent Claim 50 words
A compound of claim 2 wherein X is ##STR483## R 7 is hydrogen, cyclohexyl, lower alkoxy of 1 to 4 carbons, ##STR484## m is zero, one or two; R 13 is hydrogen, methyl, methoxy, methylthio, bromo, fluoro, or hydroxy; and R 6 is hydrogen, ##STR485## or an alkali metal salt.
Claim 5
Dependent Claim 39 words
A compound of claim 3 wherein: R 1 is phenyl; R 2 is phenylmethyl or phenylethyl; R 3 is hydrogen, alkali metal salt, ethyl, benzyl, ##STR486## and R 23 is methyl or --(CH 2 ) 4 --NH 2 .
Claim 6
Dependent Claim 9 words
A compound of claim 4 wherein X is ##STR487##
Claim 7
Dependent Claim 27 words
A compound of claim 5 wherein R 2 is phenylmethyl and R 3 and R 6 are the same and each is hydrogen, sodium, potassium or lithium.
Claim 8
Dependent Claim 6 words
The compound of claim 6, 1-[(S)-2-[[[2-(benzoylamino)-3-phenylpropyl]hydroxyphosphinyl]oxy]-1-oxopropyl]-L-proline.
Claim 9
Dependent Claim 45 words
A composition useful for treating hypertension comprising a pharmaceutically acceptable carrier and a hypotensive agent or pharmaceutically acceptable salt thereof of the formula ##STR488## wherein R 1 , R 2 , R 3 , R 23 , and X are as defined in claim 1.
Claim 10
Dependent Claim 21 words
The method of alleviating hypertension in a mammalian species which comprises administering an effective amount of the composition of claim 8.

References Cited (Backward Citations)

US4168267A Cited
US4379146A Cited
US4374131A Cited
US4432972A Cited
US4432971A Cited
US4555506A Cited
US4452790A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-12-28 1991-06-29 1991-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-12-28 1995-06-29 1995-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-12-28 1999-06-29 1999-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag